We recognize it is not just “what we do” that matters, but also “how we do it” that defines corporate responsibility at Pfizer. We face many challenges in meeting these new responsibilities. How can we manage our growth responsibly while also responsibly handling contractions in our business? How can we embed our approach to responsibility into decision-making in all parts of the business and all places where we do business? And how can we capitalize on the proposed Wyeth acquisition to meet the ever-evolving expectations of our stakeholders?
Our Approach ›